Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 9 studies | 31% ± 14% | |
| epithelial cell | 7 studies | 41% ± 24% | |
| smooth muscle cell | 6 studies | 20% ± 3% | |
| basal cell | 6 studies | 27% ± 12% | |
| endothelial cell | 5 studies | 26% ± 4% | |
| abnormal cell | 4 studies | 24% ± 6% | |
| plasma cell | 4 studies | 29% ± 12% | |
| enterocyte | 4 studies | 20% ± 4% | |
| goblet cell | 4 studies | 25% ± 7% | |
| pericyte | 4 studies | 18% ± 1% | |
| ionocyte | 3 studies | 32% ± 5% | |
| myofibroblast cell | 3 studies | 19% ± 2% | |
| retinal cone cell | 3 studies | 53% ± 6% | |
| secretory cell | 3 studies | 27% ± 13% | |
| neuron | 3 studies | 23% ± 6% | |
| hepatocyte | 3 studies | 38% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 4941.85 | 226 / 226 | 100% | 103.73 | 406 / 406 |
| ovary | 100% | 1590.82 | 180 / 180 | 100% | 70.10 | 430 / 430 |
| thymus | 100% | 4988.95 | 653 / 653 | 100% | 110.37 | 604 / 605 |
| brain | 100% | 1725.21 | 2636 / 2642 | 100% | 52.30 | 704 / 705 |
| adrenal gland | 100% | 2277.86 | 258 / 258 | 100% | 47.22 | 229 / 230 |
| kidney | 100% | 4520.27 | 89 / 89 | 100% | 91.26 | 897 / 901 |
| esophagus | 100% | 2484.84 | 1445 / 1445 | 99% | 33.40 | 182 / 183 |
| pancreas | 100% | 1823.74 | 328 / 328 | 99% | 43.03 | 177 / 178 |
| uterus | 100% | 2083.72 | 170 / 170 | 99% | 72.45 | 456 / 459 |
| prostate | 100% | 2518.74 | 245 / 245 | 99% | 86.53 | 498 / 502 |
| intestine | 100% | 2866.93 | 966 / 966 | 99% | 57.77 | 522 / 527 |
| stomach | 100% | 2246.74 | 359 / 359 | 99% | 48.69 | 282 / 286 |
| breast | 100% | 2292.26 | 459 / 459 | 98% | 63.93 | 1101 / 1118 |
| bladder | 100% | 2110.29 | 21 / 21 | 98% | 54.73 | 495 / 504 |
| skin | 100% | 2048.73 | 1809 / 1809 | 97% | 39.49 | 459 / 472 |
| lung | 99% | 1674.14 | 574 / 578 | 98% | 42.61 | 1130 / 1155 |
| eye | 0% | 0 | 0 / 0 | 100% | 69.13 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 51.03 | 29 / 29 |
| muscle | 100% | 5101.60 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1535.20 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 66.80 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 40.53 | 1 / 1 |
| adipose | 100% | 2113.30 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1704.33 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 4099.09 | 855 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 67% | 770.07 | 623 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006635 | Biological process | fatty acid beta-oxidation |
| GO_0005759 | Cellular component | mitochondrial matrix |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0016863 | Molecular function | intramolecular oxidoreductase activity, transposing C=C bonds |
| GO_0004165 | Molecular function | delta(3)-delta(2)-enoyl-CoA isomerase activity |
| Gene name | ECI1 |
| Protein name | Enoyl-CoA delta isomerase 1 DCI protein (Dodecenoyl-Coenzyme A delta isomerase (3,2 trans-enoyl-Coenzyme A isomerase), isoform CRA_a) (Enoyl-CoA delta isomerase 1) Enoyl-CoA delta isomerase 1, mitochondrial (EC 5.3.3.8) (3,2-trans-enoyl-CoA isomerase) (Delta(3),Delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase) |
| Synonyms | hCG_41028 DCI |
| Description | FUNCTION: Key enzyme of fatty acid beta-oxidation (Probable). Able to isomerize both 3-cis (3Z) and 3-trans (3E) double bonds into the 2-trans (2E) form in a range of enoyl-CoA species, with a preference for (3Z)-enoyl-CoAs over (3E)-enoyl-CoAs (By similarity). The catalytic efficiency of this enzyme is not affected by the fatty acyl chain length (By similarity). . |
| Accessions | ENST00000562238.5 [P42126-2] Q96DC0 ENST00000570258.5 H3BS70 ENST00000566379.1 ENST00000301729.9 [P42126-1] P42126 |